Back

Beta-blocker therapy and risk of dementia: a population-based prospective study

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Use benefit and risk of pharmacotherapy Beta-Blockers ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Hannes Holm

Skane University Hospital, Malmo (Sweden)

6 More presentations in this session

Presentation thumbnail
Professor A. Kane (Saint-Louis, SN)
Abstract Slides
Presentation thumbnail
Doctor A. Mohammad (Hyderabad, IN)
Abstract
Presentation thumbnail
Doctor J. Sousa (Porto, PT)
Abstract Slides
Presentation thumbnail
Professor C. Chen (Wuhan, CN)
Presentation thumbnail
Professor J. Salem (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Use benefit and risk of pharmacotherapy

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
thumbnail
Congress Presentation
Betablockers post-acute myocardial infarction
thumbnail
Congress Presentation
Discussant review - REBOOT-CNIC, BETAMI-DANBLOCK, CAPITAL-RCT

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources